Mrp4 Confers Resistance to Topotecan and Protects the Brain from Chemotherapy
The role of the multidrug resistance protein MRP4/ABCC4 in vivo remains undefined. To explore this role, we generated Mrp4-deficient mice. Unexpectedly, these mice showed enhanced accumulation of the anticancer agent topotecan in brain tissue and cerebrospinal fluid (CSF). Further studies demonstrat...
Guardat en:
| Publicat a: | Mol Cell Biol |
|---|---|
| Autors principals: | , , , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Taylor & Francis
2004
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC506999/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15314169/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/MCB.24.17.7612-7621.2004 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
